/CL
CL Stock - Colgate-Palmolive Company
Consumer Defensive|Household & Personal ProductsNYSE
$78.36+0.81%
+$0.63 (+0.81%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.38
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).73
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+11.3%upside
Target: $87.21
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$77.58 – $79.14
TARGET (TP)$87.25
STOP LOSS$72.09
RISK/REWARD1:1.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.29
52W High$100.18
52W Low$74.55
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B |
| Gross Profit | $12.11B | $11.25B | $10.15B | $10.29B | $9.93B |
| Gross Margin | 60.2% | 57.8% | 56.5% | 59.1% | 60.3% |
| Operating Income | $4.38B | $4.13B | $3.58B | $3.89B | $3.91B |
| Net Income | $2.89B | $2.30B | $1.78B | $2.17B | $2.69B |
| Net Margin | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% |
| EPS | $3.53 | $2.78 | $2.13 | $2.56 | $3.15 |
Company Overview
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
10
56%
Hold / Neutral
8
44%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
10 Bullish8 Neutral/Bearish
Price Targets
$92
Average Target
↑ 18.0% Upside
Now
$79
Low
$92
Average
$121
High
Based on 19 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 11th 2025 | Argus | Downgrade | Hold | - |
| December 9th 2025 | RBC Capital Mkts | Upgrade | Outperform | $88 |
| October 3rd 2025 | Piper Sandler | Resumed | Neutral | $84 |
| October 28th 2024 | Stifel | Downgrade | Hold | $101← $105 |
| September 24th 2024 | Piper Sandler | Initiation | Overweight | $121 |
| September 16th 2024 | Wells Fargo | Downgrade | Underweight | $100 |
| September 9th 2024 | Deutsche Bank | Downgrade | Hold | $109← $107 |
| July 26th 2024 | HSBC Securities | Downgrade | Hold | - |
| July 24th 2024 | Jefferies | Downgrade | Hold | $95← $103 |
| July 23rd 2024 | TD Cowen | Initiation | Buy | $110 |
| June 24th 2024 | Exane BNP Paribas | Initiation | Outperform | $109 |
| March 1st 2024 | Goldman | Resumed | Buy | $93 |
| January 29th 2024 | Raymond James | Upgrade | Outperform | - |
| December 15th 2023 | BofA Securities | Upgrade | Buy | $90 |
| November 13th 2023 | Jefferies | Initiation | Buy | $87 |
Earnings History & Surprises
CLBeat Rate
78%
Last 18 quarters
Avg Surprise
+2.6%
EPS vs Estimate
Beats / Misses
14/0
4 met exactly
Latest EPS
$0.91
Q4 2025
EPS Surprise History
Q1 24
+2.4%
$0.87vs$0.85
Q2 24
+6.2%
$0.86vs$0.81
Q3 24
+4.6%
$0.91vs$0.87
Q4 24
+2.2%
$0.91vs$0.89
Q1 25
+1.1%
$0.91vs$0.90
Q2 25
+6.3%
$0.91vs$0.86
Q3 25
+2.6%
$0.92vs$0.90
Q4 25
+2.4%
$0.91vs$0.89
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 23, 2026 | — | — | — | — |
Q1 2026 | Jan 30, 2026 | $0.92 | — | — | — |
Q4 2025 | Oct 31, 2025 | $0.89 | $0.91 | +2.4% | ✓ BEAT |
Q3 2025 | Aug 1, 2025 | $0.90 | $0.92 | +2.6% | ✓ BEAT |
Q2 2025 | Apr 25, 2025 | $0.86 | $0.91 | +6.3% | ✓ BEAT |
Q1 2025 | Jan 31, 2025 | $0.90 | $0.91 | +1.1% | ✓ BEAT |
Q4 2024 | Oct 25, 2024 | $0.89 | $0.91 | +2.2% | ✓ BEAT |
Q3 2024 | Jul 26, 2024 | $0.87 | $0.91 | +4.6% | ✓ BEAT |
Q2 2024 | Apr 26, 2024 | $0.81 | $0.86 | +6.2% | ✓ BEAT |
Q1 2024 | Jan 26, 2024 | $0.85 | $0.87 | +2.4% | ✓ BEAT |
Q4 2023 | Oct 27, 2023 | $0.80 | $0.86 | +7.5% | ✓ BEAT |
Q3 2023 | Jul 28, 2023 | $0.75 | $0.77 | +2.7% | ✓ BEAT |
Q2 2023 | Apr 28, 2023 | $0.70 | $0.73 | +4.3% | ✓ BEAT |
Q1 2023 | Jan 27, 2023 | $0.77 | $0.77 | 0.0% | = MET |
Q4 2022 | Oct 28, 2022 | $0.73 | $0.74 | +1.4% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | $0.71 | $0.72 | +1.4% | ✓ BEAT |
Q2 2022 | Apr 29, 2022 | $0.74 | $0.74 | 0.0% | = MET |
Q1 2022 | Jan 28, 2022 | $0.79 | $0.79 | 0.0% | = MET |
Q4 2021 | Oct 29, 2021 | $0.79 | $0.81 | +2.5% | ✓ BEAT |
Q3 2021 | Jul 30, 2021 | $0.80 | $0.80 | 0.0% | = MET |
Latest News
JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $88
📈 PositiveBenzinga•Dec 18, 2025, 04:33 PM
Argus Research Downgrades Colgate-Palmolive to Hold
📉 NegativeBenzinga•Dec 11, 2025, 12:44 PM
RBC Capital Upgrades Colgate-Palmolive to Outperform, Announces $88 Price Target
📈 PositiveBenzinga•Dec 9, 2025, 11:56 AM
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
➖ NeutralBenzinga•Nov 4, 2025, 02:12 PM•Also:
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
➖ NeutralBenzinga•Nov 3, 2025, 09:12 PM
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
➖ NeutralBenzinga•Nov 3, 2025, 07:28 PM•Also:
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
➖ NeutralBenzinga•Nov 3, 2025, 05:50 PM
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
➖ NeutralBenzinga•Nov 3, 2025, 04:05 PM
Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94
➖ NeutralBenzinga•Nov 3, 2025, 02:10 PM
Wells Fargo Maintains Underweight on Colgate-Palmolive, Lowers Price Target to $77
📉 NegativeBenzinga•Nov 3, 2025, 02:08 PM
Colgate-Palmolive Q3 Adj. EPS $0.91 Beats $0.89 Estimate, Sales $5.131B Inline
📈 PositiveBenzinga•Oct 31, 2025, 10:55 AM
Raymond James Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $95
➖ NeutralBenzinga•Oct 20, 2025, 05:27 PM
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $88
➖ NeutralBenzinga•Oct 10, 2025, 01:20 PM•Also:
B of A Securities Maintains Buy on Colgate-Palmolive, Lowers Price Target to $88
➖ NeutralBenzinga•Oct 8, 2025, 06:00 PM
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $92
➖ NeutralBenzinga•Oct 8, 2025, 04:11 PM
Piper Sandler Assumes Colgate-Palmolive at Neutral, Announces Price Target of $84
➖ NeutralBenzinga•Oct 3, 2025, 03:06 PM
Goldman Sachs Maintains Buy on Colgate-Palmolive, Lowers Price Target to $91
➖ NeutralBenzinga•Oct 2, 2025, 05:29 PM
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $82
➖ NeutralBenzinga•Oct 1, 2025, 03:13 PM•Also:
Wells Fargo Maintains Underweight on Colgate-Palmolive, Lowers Price Target to $80
📉 NegativeBenzinga•Sep 25, 2025, 01:23 PM
'Attorney General Ken Paxton And Colgate-Palmolive Lead The Way In Toothpaste Safety With Historic Agreement To Prevent Excessive Fluoride Exposure' - Texas AG Ken Paxton
📈 PositiveBenzinga•Sep 15, 2025, 03:46 PM
Frequently Asked Questions about CL
What is CL's current stock price?
Colgate-Palmolive Company (CL) is currently trading at $78.36 per share. The stock has moved +0.81% today.
What is the analyst price target for CL?
The average analyst price target for CL is $87.25, based on 1 analyst.
What sector is Colgate-Palmolive Company in?
Colgate-Palmolive Company operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the NYSE exchange.
What is CL's market cap?
Colgate-Palmolive Company has a market capitalization of $63.17 billion, making it a large-cap company.
Does CL pay dividends?
No, Colgate-Palmolive Company does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive SectorCCEP
Coca-Cola Europacific Partners PLC
$92.14
Mkt Cap: $42.3B
CHD
Church & Dwight Co., Inc.
$85.08
Mkt Cap: $20.8B
CLX
The Clorox Company
$98.31
Mkt Cap: $12.0B
DEO
Diageo plc
$89.16
Mkt Cap: $49.5B
EL
The Estée Lauder Companies Inc.
$108.00
Mkt Cap: $38.9B
KMB
Kimberly-Clark Corporation
$100.65
Mkt Cap: $33.4B
KR
The Kroger Co.
$62.41
Mkt Cap: $41.4B
KVUE
Kenvue Inc.
$17.02
Mkt Cap: $32.6B
MDLZ
Mondelez International, Inc.
$54.50
Mkt Cap: $70.4B
MNST
Monster Beverage Corporation
$76.26
Mkt Cap: $74.5B
Explore stocks similar to CL for comparison